Compositions and methods for reducing oxidative damage Grant US-11701375-B2 United States of America 18 Jul 2023
Ophthalmic compositions and methods for reducing oxidative damage to an eye lens Grant US-11406591-B2 United States of America 09 Aug 2022
Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral… Grant US-10869831-B2 United States of America 22 Dec 2020
Compositions and methods for treating an aggregation disease or disorder Grant US-10751353-B2 United States of America 25 Aug 2020
Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral… Application US-10493023-B2 United States of America 03 Dec 2019
Compositions and methods for reducing oxidative damage Grant US-10195225-B2 United States of America 05 Feb 2019
OPHTHALMIC COMPOSITIONS AND METHODS FOR REDUCING OXIDATIVE DAMAGE TO AN EYE LENS Application EP-3256136-A4 European Patent Office 21 Nov 2018
OPHTHALMIC COMPOSITION COMPRISING CYCLOSPORINE AND TREHALOSE Application EP-3213763-A4 European Patent Office 18 Jul 2018
Compositions and methods for reducing oxidative damage Grant US-9555054-B2 United States of America 31 Jan 2017
TREATMENT OF PROTEIN AGGREGATION MYOPATHIC AND NEURODEGENERATIVE DISEASES BY PARENTERAL… Application WO-2014181333-A3 World Intellectual Property Organisation (WIPO) 08 Jan 2015